- Home
- OSK vs RVMD Comparison
OSK vs RVMD Comparison
Compare OSK & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSK
- RVMD
- Stock Information
- Founded
- OSK 1917
- RVMD 2014
- Country
- OSK United States
- RVMD United States
- Employees
- OSK N/A
- RVMD N/A
- Industry
- OSK Auto Manufacturing
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OSK Consumer Discretionary
- RVMD Health Care
- Exchange
- OSK Nasdaq
- RVMD Nasdaq
- Market Cap
- OSK 7.3B
- RVMD 8.7B
- IPO Year
- OSK N/A
- RVMD 2020
- Fundamental
- Price
- OSK $98.39
- RVMD $39.21
- Analyst Decision
- OSK Buy
- RVMD Strong Buy
- Analyst Count
- OSK 14
- RVMD 13
- Target Price
- OSK $127.21
- RVMD $67.77
- AVG Volume (30 Days)
- OSK 693.5K
- RVMD 1.3M
- Earning Date
- OSK 04-24-2025
- RVMD 02-26-2025
- Dividend Yield
- OSK 2.07%
- RVMD N/A
- EPS Growth
- OSK 13.99
- RVMD N/A
- EPS
- OSK 10.35
- RVMD N/A
- Revenue
- OSK $10,730,200,000.00
- RVMD N/A
- Revenue This Year
- OSK N/A
- RVMD N/A
- Revenue Next Year
- OSK $5.42
- RVMD N/A
- P/E Ratio
- OSK $9.50
- RVMD N/A
- Revenue Growth
- OSK 11.10
- RVMD N/A
- 52 Week Low
- OSK $89.08
- RVMD $29.55
- 52 Week High
- OSK $127.98
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- OSK 41.16
- RVMD 42.01
- Support Level
- OSK $93.19
- RVMD $37.33
- Resistance Level
- OSK $98.96
- RVMD $39.71
- Average True Range (ATR)
- OSK 3.54
- RVMD 1.69
- MACD
- OSK -1.24
- RVMD -0.14
- Stochastic Oscillator
- OSK 28.45
- RVMD 33.51
About OSK Oshkosh Corporation (Holding Company)Common Stock
Oshkosh is the top producer of access equipment, specialty vehicles, and military trucks. It serves diverse end markets, where it is typically the market share leader in North America, or, in the case of JLG aerial work platforms, a global leader. The company had manufactured joint light tactical vehicles for the us Department of Defense. However, Oshkosh recently lost the JLTV recompete, bringing into focus its us Postal Service contract, which calls for the electrification of us postal vehicles. The company reports in three segments—access equipment (52% of revenue), defense (22%), and vocational (27%)—and generated $9.6 billion in revenue in 2023.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.